News
Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for excessive eating in rare disorder Prader-Willi syndrome.
Amvuttra (vutrisiran) Transthyretin-directed small interfering RNA therapeutic Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here." The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as ...
Approval was based on results from the Phase III ALIGN study, which demonstrated a significant reduction in proteinuria at 36 weeks in patients with primary immunoglobulin A nephropathy. Results from ...
As of 12:36:25 PM EDT. Market Open.
At close: April 4 at 4:00:01 PM EDT ...
Věděli jste, proč je důležité agresorovi vykat a jak naše ruce dokážou vyřešit až 90 % konfliktů? Instruktorka také ukázala, které obranné prostředky skutečně fungují a které ne. Jak šli základy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results